These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9790480)

  • 21. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M; Murray C; Buchwald D; Levine H; Cheney P; Peterson D; Komaroff AL; Ritz J
    J Immunol; 1987 Nov; 139(10):3306-13. PubMed ID: 2824604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic tracks in fatigue syndromes.
    Moutschen M; Triffaux JM; Demonty J; Legros JJ; Lefèbvre PJ
    Acta Clin Belg; 1994; 49(6):274-89. PubMed ID: 7871934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
    Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
    Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic fatigue syndrome and the immune system: Where are we now?
    Mensah FKF; Bansal AS; Ford B; Cambridge G
    Neurophysiol Clin; 2017 Apr; 47(2):131-138. PubMed ID: 28410877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital].
    Nishikai M
    Nihon Rinsho; 1992 Nov; 50(11):2641-7. PubMed ID: 1337560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic fatigue syndrome: an update.
    Komaroff AL; Buchwald DS
    Annu Rev Med; 1998; 49():1-13. PubMed ID: 9509246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug targets in stress-related disorders.
    Covelli V; Passeri ME; Leogrande D; Jirillo E; Amati L
    Curr Med Chem; 2005; 12(15):1801-9. PubMed ID: 16029148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is human herpesvirus-6 a trigger for chronic fatigue syndrome?
    Komaroff AL
    J Clin Virol; 2006 Dec; 37 Suppl 1():S39-46. PubMed ID: 17276367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals.
    Glass JM; Lyden AK; Petzke F; Stein P; Whalen G; Ambrose K; Chrousos G; Clauw DJ
    J Psychosom Res; 2004 Oct; 57(4):391-8. PubMed ID: 15518675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why did I get chronic fatigue syndrome? A qualitative interview study of causal attributions in women patients.
    Soderlund A; Malterud K
    Scand J Prim Health Care; 2005 Dec; 23(4):242-7. PubMed ID: 16272074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Overview of our patients with chronic fatigue syndrome (CFS) from the pathoetiological aspects].
    Matsuda J; Gohchi K
    Nihon Rinsho; 1992 Nov; 50(11):2635-40. PubMed ID: 1287240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychobehavioral and immunological characteristics of adult people with chronic fatigue and patients with chronic fatigue syndrome.
    Masuda A; Nozoe SI; Matsuyama T; Tanaka H
    Psychosom Med; 1994; 56(6):512-8. PubMed ID: 7871106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic fatigue syndrome: a manifestation of Epstein-Barr virus infection?
    Schooley RT
    Curr Clin Top Infect Dis; 1988; 9():126-46. PubMed ID: 2855828
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
    Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
    Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Overview of chronic fatigue syndrome focusing on prevalence and diagnostic criteria].
    Kuratsune H
    Nihon Rinsho; 2007 Jun; 65(6):983-90. PubMed ID: 17561686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic fatigue syndrome: a psychoneuroimmunological perspective].
    van Houdenhove B; Heijnen CJ
    Tijdschr Psychiatr; 2009; 51(8):603-10. PubMed ID: 19658073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.